医学
宫颈癌
彭布罗利珠单抗
放化疗
放射治疗
肿瘤科
阶段（地层学）
养生
内科学
核医学
癌症
免疫疗法
生物
古生物学
作者
Domenica Lorusso,Yang Xiang,K. Hasegawa,Giovanni Scambia,M.H. Leiva Galves,Pierre Elias,Andrés Acevedo,Júlia Vízkeleti,A.J.P.D.S. Gomes,Fernando Contreras Mejía,Allison B. Reiss,Asude Ayhan,J-Y Lee,В. В. Саевец,Flora Zagouri,K. Li,K.U. Yamada,Sarper Toker,Sandro Pignata,Linda Duska
标识
DOI：10.1016/j.annonc.2023.10.032
摘要
Pembrolizumab (pembro) has shown efficacy in patients (pts) with cervical cancer. The effect of chemoradiotherapy may be enhanced by immunotherapy. ENGOT-cx11/GOG-3047/KEYNOTE-A18(NCT04221945) assessed the efficacy and safety of pembro + concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI
爱静静
寻道图强
张子捷
spark810
乐乐乐乐乐乐
tuanheqi
Henry
杳鸢
shinysparrow
YifanWang
nenoaowu
VDC
火火
priss111
活泼蜜蜂
iWatchTheMoon
ss25
传奇3
五十一笑声
缓慢的枫叶
皖公网安备34019202002308
